nodes	percent_of_prediction	percent_of_DWPC	metapath
Pranlukast—MUC2—brainstem—endogenous depression	0.0379	0.092	CbGeAlD
Pranlukast—IL5—Glucocorticoid receptor regulatory network—FKBP5—endogenous depression	0.0373	0.0634	CbGpPWpGaD
Pranlukast—MUC2—forebrain—endogenous depression	0.0366	0.0888	CbGeAlD
Pranlukast—IL5—endocrine gland—endogenous depression	0.0276	0.067	CbGeAlD
Pranlukast—MUC2—endocrine gland—endogenous depression	0.0212	0.0515	CbGeAlD
Pranlukast—NFKB1—forebrain—endogenous depression	0.0209	0.0506	CbGeAlD
Pranlukast—ABCC2—Codeine and Morphine Metabolism—CYP2D6—endogenous depression	0.0205	0.0348	CbGpPWpGaD
Pranlukast—MUC2—nervous system—endogenous depression	0.0199	0.0482	CbGeAlD
Pranlukast—MUC2—central nervous system—endogenous depression	0.0191	0.0464	CbGeAlD
Pranlukast—MUC2—cerebellum—endogenous depression	0.0187	0.0454	CbGeAlD
Pranlukast—IL5—Cytokines and Inflammatory Response—IL10—endogenous depression	0.0186	0.0316	CbGpPWpGaD
Pranlukast—NFKB1—cardiovascular system—endogenous depression	0.0176	0.0428	CbGeAlD
Pranlukast—IL5—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—GATA3—endogenous depression	0.0164	0.0279	CbGpPWpGaD
Pranlukast—NFKB1—pituitary gland—endogenous depression	0.0156	0.0379	CbGeAlD
Pranlukast—MUC2—brain—endogenous depression	0.0152	0.0368	CbGeAlD
Pranlukast—NFKB1—Glucocorticoid receptor regulatory network—FKBP5—endogenous depression	0.0151	0.0258	CbGpPWpGaD
Pranlukast—TNF—Matrix Metalloproteinases—MMP16—endogenous depression	0.0148	0.0252	CbGpPWpGaD
Pranlukast—NFKB1—adrenal gland—endogenous depression	0.014	0.0339	CbGeAlD
Pranlukast—CYSLTR1—adrenal gland—endogenous depression	0.0137	0.0333	CbGeAlD
Pranlukast—NFKB1—thyroid gland—endogenous depression	0.0135	0.0327	CbGeAlD
Pranlukast—NFKB1—endocrine gland—endogenous depression	0.0121	0.0294	CbGeAlD
Pranlukast—CYSLTR1—endocrine gland—endogenous depression	0.0119	0.0288	CbGeAlD
Pranlukast—NFKB1—nervous system—endogenous depression	0.0113	0.0275	CbGeAlD
Pranlukast—IL5—Regulation of nuclear SMAD2/3 signaling—GATA3—endogenous depression	0.0111	0.0189	CbGpPWpGaD
Pranlukast—CYSLTR1—nervous system—endogenous depression	0.0111	0.027	CbGeAlD
Pranlukast—IL5—Glucocorticoid receptor regulatory network—GATA3—endogenous depression	0.011	0.0188	CbGpPWpGaD
Pranlukast—NFKB1—central nervous system—endogenous depression	0.0109	0.0265	CbGeAlD
Pranlukast—CYSLTR1—central nervous system—endogenous depression	0.0107	0.026	CbGeAlD
Pranlukast—NFKB1—cerebellum—endogenous depression	0.0107	0.0259	CbGeAlD
Pranlukast—NFKB1—Melatonin metabolism and effects—CYP2D6—endogenous depression	0.0103	0.0175	CbGpPWpGaD
Pranlukast—CYP3A4—Farnesoid X Receptor  Pathway—FKBP5—endogenous depression	0.01	0.0171	CbGpPWpGaD
Pranlukast—IL5—IL4-mediated signaling events—IL10—endogenous depression	0.00956	0.0163	CbGpPWpGaD
Pranlukast—TNF—Monoamine Transport—TPH2—endogenous depression	0.00907	0.0154	CbGpPWpGaD
Pranlukast—IL5—AP-1 transcription factor network—IL10—endogenous depression	0.00868	0.0148	CbGpPWpGaD
Pranlukast—NFKB1—brain—endogenous depression	0.00866	0.021	CbGeAlD
Pranlukast—TNF—IL27-mediated signaling events—GATA3—endogenous depression	0.00856	0.0146	CbGpPWpGaD
Pranlukast—CYSLTR1—brain—endogenous depression	0.0085	0.0206	CbGeAlD
Pranlukast—IL5—AP-1 transcription factor network—NR3C1—endogenous depression	0.00803	0.0137	CbGpPWpGaD
Pranlukast—IL5—Allograft Rejection—IL10—endogenous depression	0.00788	0.0134	CbGpPWpGaD
Pranlukast—NFKB1—Melatonin metabolism and effects—MAOA—endogenous depression	0.00775	0.0132	CbGpPWpGaD
Pranlukast—IL5—Regulation of nuclear SMAD2/3 signaling—IL10—endogenous depression	0.00772	0.0131	CbGpPWpGaD
Pranlukast—NFKB1—Oxidative Stress—MAOA—endogenous depression	0.00754	0.0128	CbGpPWpGaD
Pranlukast—TNF—Monoamine Transport—SLC6A4—endogenous depression	0.00725	0.0123	CbGpPWpGaD
Pranlukast—IL5—Regulation of nuclear SMAD2/3 signaling—NR3C1—endogenous depression	0.00714	0.0121	CbGpPWpGaD
Pranlukast—IL5—Glucocorticoid receptor regulatory network—NR3C1—endogenous depression	0.00707	0.012	CbGpPWpGaD
Pranlukast—CYP2C9—CYP2E1 reactions—CYP2D6—endogenous depression	0.00698	0.0119	CbGpPWpGaD
Pranlukast—TNF—Transcription factor regulation in adipogenesis—NR3C1—endogenous depression	0.00627	0.0107	CbGpPWpGaD
Pranlukast—NFKB1—IL-4 Signaling Pathway—GATA3—endogenous depression	0.00626	0.0106	CbGpPWpGaD
Pranlukast—CYP3A4—Codeine and Morphine Metabolism—CYP2D6—endogenous depression	0.00594	0.0101	CbGpPWpGaD
Pranlukast—TNF—Cytokines and Inflammatory Response—IL10—endogenous depression	0.00576	0.00979	CbGpPWpGaD
Pranlukast—NFKB1—Notch Signaling Pathway—GATA3—endogenous depression	0.00568	0.00966	CbGpPWpGaD
Pranlukast—ABCC2—adrenal gland—endogenous depression	0.00548	0.0133	CbGeAlD
Pranlukast—IL5—Glucocorticoid receptor regulatory network—POMC—endogenous depression	0.0054	0.00919	CbGpPWpGaD
Pranlukast—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—GATA3—endogenous depression	0.00507	0.00863	CbGpPWpGaD
Pranlukast—ABCC2—endocrine gland—endogenous depression	0.00475	0.0115	CbGeAlD
Pranlukast—CYP2C9—cardiovascular system—endogenous depression	0.00461	0.0112	CbGeAlD
Pranlukast—NFKB1—Glucocorticoid receptor regulatory network—GATA3—endogenous depression	0.00448	0.00762	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—TPH1—endogenous depression	0.00442	0.00752	CbGpPWpGaD
Pranlukast—CYSLTR1—G alpha (q) signalling events—OXT—endogenous depression	0.0044	0.00749	CbGpPWpGaD
Pranlukast—NFKB1—Corticotropin-releasing hormone—CRH—endogenous depression	0.0044	0.00748	CbGpPWpGaD
Pranlukast—CYP2C9—Xenobiotics—CYP2D6—endogenous depression	0.00432	0.00735	CbGpPWpGaD
Pranlukast—NFKB1—TCR Signaling Pathway—GATA3—endogenous depression	0.00416	0.00708	CbGpPWpGaD
Pranlukast—CYP2C9—Tamoxifen metabolism—CYP2D6—endogenous depression	0.00416	0.00707	CbGpPWpGaD
Pranlukast—CYSLTR1—G alpha (q) signalling events—HTR2C—endogenous depression	0.00409	0.00696	CbGpPWpGaD
Pranlukast—TNF—Alzheimers Disease—CACNA1C—endogenous depression	0.00402	0.00685	CbGpPWpGaD
Pranlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—OXT—endogenous depression	0.00394	0.0067	CbGpPWpGaD
Pranlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—endogenous depression	0.00366	0.00623	CbGpPWpGaD
Pranlukast—NFKB1—Myometrial Relaxation and Contraction Pathways—ADM—endogenous depression	0.00346	0.00588	CbGpPWpGaD
Pranlukast—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—endogenous depression	0.00341	0.0058	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—TPH1—endogenous depression	0.00337	0.00573	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—TPH2—endogenous depression	0.00335	0.0057	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—HTR1A—endogenous depression	0.00328	0.00557	CbGpPWpGaD
Pranlukast—CYP2C9—endocrine gland—endogenous depression	0.00316	0.00768	CbGeAlD
Pranlukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—HTR2C—endogenous depression	0.00316	0.00538	CbGpPWpGaD
Pranlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—OXT—endogenous depression	0.00292	0.00496	CbGpPWpGaD
Pranlukast—NFKB1—Myometrial Relaxation and Contraction Pathways—OXT—endogenous depression	0.0029	0.00493	CbGpPWpGaD
Pranlukast—NFKB1—Myometrial Relaxation and Contraction Pathways—CRH—endogenous depression	0.0029	0.00493	CbGpPWpGaD
Pranlukast—NFKB1—Glucocorticoid receptor regulatory network—NR3C1—endogenous depression	0.00287	0.00489	CbGpPWpGaD
Pranlukast—CYP3A4—Xenobiotics—CYP2D6—endogenous depression	0.00285	0.00485	CbGpPWpGaD
Pranlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—HTR1A—endogenous depression	0.00281	0.00477	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—HTR1A—endogenous depression	0.00277	0.00472	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—HTR7—endogenous depression	0.00277	0.00471	CbGpPWpGaD
Pranlukast—CYP3A4—Tamoxifen metabolism—CYP2D6—endogenous depression	0.00274	0.00466	CbGpPWpGaD
Pranlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—HTR2C—endogenous depression	0.00271	0.00461	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—SLC6A4—endogenous depression	0.00268	0.00456	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—GATA3—endogenous depression	0.00268	0.00456	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—ADM—endogenous depression	0.00265	0.00451	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—GATA3—endogenous depression	0.00257	0.00437	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—TPH2—endogenous depression	0.00255	0.00434	CbGpPWpGaD
Pranlukast—CYSLTR1—G alpha (q) signalling events—HTR2A—endogenous depression	0.00251	0.00427	CbGpPWpGaD
Pranlukast—TNF—Allograft Rejection—IL10—endogenous depression	0.00244	0.00415	CbGpPWpGaD
Pranlukast—CYP3A4—Tryptophan metabolism—TPH1—endogenous depression	0.00242	0.00411	CbGpPWpGaD
Pranlukast—CYP3A4—endocrine gland—endogenous depression	0.00241	0.00586	CbGeAlD
Pranlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—HTR7—endogenous depression	0.00237	0.00404	CbGpPWpGaD
Pranlukast—TNF—Adipogenesis—GATA3—endogenous depression	0.00236	0.00402	CbGpPWpGaD
Pranlukast—CYP3A4—Estrogen metabolism—COMT—endogenous depression	0.00235	0.004	CbGpPWpGaD
Pranlukast—CYP3A4—nervous system—endogenous depression	0.00226	0.00548	CbGeAlD
Pranlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—endogenous depression	0.00225	0.00382	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—OXT—endogenous depression	0.00222	0.00378	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—CRH—endogenous depression	0.00222	0.00378	CbGpPWpGaD
Pranlukast—NFKB1—Glucocorticoid receptor regulatory network—POMC—endogenous depression	0.0022	0.00373	CbGpPWpGaD
Pranlukast—CYP3A4—central nervous system—endogenous depression	0.00217	0.00528	CbGeAlD
Pranlukast—CYSLTR1—GPCR ligand binding—HTR1A—endogenous depression	0.00214	0.00364	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—HTR1A—endogenous depression	0.00211	0.00359	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—ADM—endogenous depression	0.00209	0.00355	CbGpPWpGaD
Pranlukast—NFKB1—BDNF signaling pathway—BDNF—endogenous depression	0.00207	0.00353	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—HTR2C—endogenous depression	0.00206	0.00351	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—GATA3—endogenous depression	0.00204	0.00347	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—SLC6A4—endogenous depression	0.00204	0.00347	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—MAOA—endogenous depression	0.00202	0.00343	CbGpPWpGaD
Pranlukast—ABCC2—NRF2 pathway—SLC6A4—endogenous depression	0.00201	0.00341	CbGpPWpGaD
Pranlukast—NFKB1—Corticotropin-releasing hormone—POMC—endogenous depression	0.002	0.00341	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—BDNF—endogenous depression	0.00195	0.00331	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—HTR2A—endogenous depression	0.00194	0.0033	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—ADM—endogenous depression	0.00189	0.00322	CbGpPWpGaD
Pranlukast—IL5—Immune System—WASF2—endogenous depression	0.00189	0.00322	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—ANK3—endogenous depression	0.00189	0.00322	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—IL10—endogenous depression	0.00186	0.00316	CbGpPWpGaD
Pranlukast—MUC2—Metabolism of proteins—POMC—endogenous depression	0.00186	0.00316	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—BDNF—endogenous depression	0.00185	0.00315	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—BDNF—endogenous depression	0.00183	0.00312	CbGpPWpGaD
Pranlukast—IL5—Immune System—WASF1—endogenous depression	0.00181	0.00309	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—HTR7—endogenous depression	0.00181	0.00308	CbGpPWpGaD
Pranlukast—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2D6—endogenous depression	0.0018	0.00305	CbGpPWpGaD
Pranlukast—CYP2C9—Oxidation by Cytochrome P450—CYP2D6—endogenous depression	0.00177	0.00301	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—CRH—endogenous depression	0.00175	0.00297	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—OXT—endogenous depression	0.00175	0.00297	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—NR3C1—endogenous depression	0.00172	0.00292	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—HTR1A—endogenous depression	0.00168	0.00286	CbGpPWpGaD
Pranlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—endogenous depression	0.00166	0.00283	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—BDNF—endogenous depression	0.00165	0.00281	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—HTR2A—endogenous depression	0.00164	0.0028	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—HTR2C—endogenous depression	0.00163	0.00276	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—CRH—endogenous depression	0.00159	0.0027	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—OXT—endogenous depression	0.00159	0.0027	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—MAOA—endogenous depression	0.00154	0.00261	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—HTR1A—endogenous depression	0.00153	0.0026	CbGpPWpGaD
Pranlukast—TNF—Adipogenesis—NR3C1—endogenous depression	0.00151	0.00258	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—ADM—endogenous depression	0.0015	0.00255	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—BDNF—endogenous depression	0.00148	0.00252	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—HTR2C—endogenous depression	0.00148	0.00251	CbGpPWpGaD
Pranlukast—CYP2C9—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.00146	0.00248	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—ANK3—endogenous depression	0.00144	0.00245	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—HTR7—endogenous depression	0.00142	0.00242	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—IL10—endogenous depression	0.00141	0.00241	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—BDNF—endogenous depression	0.0014	0.00238	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—ADM—endogenous depression	0.00136	0.00231	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—CACNB2—endogenous depression	0.00133	0.00227	CbGpPWpGaD
Pranlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—POMC—endogenous depression	0.00133	0.00226	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—WASF2—endogenous depression	0.00132	0.00225	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—NR3C1—endogenous depression	0.00131	0.00223	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—HTR7—endogenous depression	0.00129	0.0022	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—HTR2A—endogenous depression	0.00127	0.00215	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—WASF1—endogenous depression	0.00127	0.00215	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—BDNF—endogenous depression	0.00126	0.00214	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—OXT—endogenous depression	0.00125	0.00213	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—CRH—endogenous depression	0.00125	0.00213	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—HTR2A—endogenous depression	0.00125	0.00213	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—WASF2—endogenous depression	0.00122	0.00208	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—CACNA1C—endogenous depression	0.00122	0.00207	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—HTR1A—endogenous depression	0.00121	0.00205	CbGpPWpGaD
Pranlukast—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—endogenous depression	0.00118	0.00201	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—WASF1—endogenous depression	0.00117	0.002	CbGpPWpGaD
Pranlukast—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—endogenous depression	0.00117	0.00199	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—HTR2C—endogenous depression	0.00117	0.00198	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—OXT—endogenous depression	0.00114	0.00194	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—CRH—endogenous depression	0.00114	0.00194	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—ADM—endogenous depression	0.00112	0.0019	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—HTR1A—endogenous depression	0.0011	0.00187	CbGpPWpGaD
Pranlukast—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.0011	0.00186	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—HTR2C—endogenous depression	0.00106	0.0018	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—HTR7—endogenous depression	0.00102	0.00174	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—CACNB2—endogenous depression	0.00102	0.00173	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—POMC—endogenous depression	0.00101	0.00172	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—HTR2A—endogenous depression	0.000997	0.0017	CbGpPWpGaD
Pranlukast—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.00096	0.00163	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—OXT—endogenous depression	0.000938	0.0016	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CRH—endogenous depression	0.000938	0.0016	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—CACNA1C—endogenous depression	0.000929	0.00158	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—HTR7—endogenous depression	0.000928	0.00158	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—HTR2A—endogenous depression	0.000905	0.00154	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—HTR1A—endogenous depression	0.000903	0.00154	CbGpPWpGaD
Pranlukast—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.00088	0.0015	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—WASF2—endogenous depression	0.000878	0.00149	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—HTR2C—endogenous depression	0.000872	0.00148	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—WASF1—endogenous depression	0.000842	0.00143	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—ADM—endogenous depression	0.000803	0.00137	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—POMC—endogenous depression	0.000796	0.00135	CbGpPWpGaD
Pranlukast—CYP2C9—Biological oxidations—CYP2D6—endogenous depression	0.000773	0.00132	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—WASF2—endogenous depression	0.000769	0.00131	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—HTR7—endogenous depression	0.000764	0.0013	CbGpPWpGaD
Pranlukast—CYP2C9—Metapathway biotransformation—CYP2D6—endogenous depression	0.000763	0.0013	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—WASF1—endogenous depression	0.000737	0.00125	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—POMC—endogenous depression	0.000723	0.00123	CbGpPWpGaD
Pranlukast—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.000722	0.00123	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—HTR2A—endogenous depression	0.000716	0.00122	CbGpPWpGaD
Pranlukast—CYP2C9—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.000713	0.00121	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CRH—endogenous depression	0.000673	0.00114	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—OXT—endogenous depression	0.000673	0.00114	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—HTR2A—endogenous depression	0.00065	0.00111	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—HTR1A—endogenous depression	0.000648	0.0011	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—HTR2C—endogenous depression	0.000626	0.00106	CbGpPWpGaD
Pranlukast—CYP2C9—Biological oxidations—COMT—endogenous depression	0.000586	0.000997	CbGpPWpGaD
Pranlukast—CYP2C9—Biological oxidations—MAOA—endogenous depression	0.000582	0.00099	CbGpPWpGaD
Pranlukast—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.00058	0.000987	CbGpPWpGaD
Pranlukast—CYP2C9—Metapathway biotransformation—COMT—endogenous depression	0.000578	0.000983	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—POMC—endogenous depression	0.000571	0.000972	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—HTR7—endogenous depression	0.000548	0.000932	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—HTR2A—endogenous depression	0.000535	0.00091	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—POMC—endogenous depression	0.000519	0.000883	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—CYP2D6—endogenous depression	0.00051	0.000867	CbGpPWpGaD
Pranlukast—CYP3A4—Metapathway biotransformation—CYP2D6—endogenous depression	0.000503	0.000855	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—WASF2—endogenous depression	0.000497	0.000846	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—WASF1—endogenous depression	0.000477	0.000811	CbGpPWpGaD
Pranlukast—CYP3A4—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.00047	0.0008	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—ADM—endogenous depression	0.000455	0.000774	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—POMC—endogenous depression	0.000427	0.000727	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—COMT—endogenous depression	0.000386	0.000657	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—HTR2A—endogenous depression	0.000384	0.000653	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—MAOA—endogenous depression	0.000384	0.000653	CbGpPWpGaD
Pranlukast—CYP3A4—Metapathway biotransformation—COMT—endogenous depression	0.000381	0.000648	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CRH—endogenous depression	0.000381	0.000648	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—OXT—endogenous depression	0.000381	0.000648	CbGpPWpGaD
Pranlukast—CYP2C9—Biological oxidations—POMC—endogenous depression	0.000379	0.000644	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—HTR1A—endogenous depression	0.000367	0.000624	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—HTR2C—endogenous depression	0.000354	0.000603	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—HTR7—endogenous depression	0.00031	0.000528	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—POMC—endogenous depression	0.000307	0.000521	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—POMC—endogenous depression	0.00025	0.000425	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—TPH1—endogenous depression	0.000218	0.000371	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—HTR2A—endogenous depression	0.000217	0.00037	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—POMC—endogenous depression	0.000174	0.000295	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—TPH2—endogenous depression	0.000165	0.000281	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CACNB2—endogenous depression	0.000165	0.000281	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—DPYD—endogenous depression	0.000163	0.000277	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CACNA1C—endogenous depression	0.000151	0.000257	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—POMC—endogenous depression	0.000145	0.000247	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—TPH1—endogenous depression	0.000144	0.000245	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CYP2D6—endogenous depression	0.000132	0.000225	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—TPH2—endogenous depression	0.000109	0.000186	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CACNB2—endogenous depression	0.000109	0.000186	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—DPYD—endogenous depression	0.000107	0.000183	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—COMT—endogenous depression	0.0001	0.00017	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CACNA1C—endogenous depression	9.98e-05	0.00017	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—MAOA—endogenous depression	9.95e-05	0.000169	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CYP2D6—endogenous depression	8.72e-05	0.000148	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—COMT—endogenous depression	6.61e-05	0.000112	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—MAOA—endogenous depression	6.56e-05	0.000112	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—POMC—endogenous depression	6.48e-05	0.00011	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—POMC—endogenous depression	4.27e-05	7.27e-05	CbGpPWpGaD
